Literature DB >> 27195451

Worse cardiac remodeling in response to pressure overload in type 2 diabetes mellitus.

N Gonçalves1, C Gomes-Ferreira1, C Moura2, R Roncon-Albuquerque1, A F Leite-Moreira3, I Falcão-Pires4.   

Abstract

BACKGROUND: Diabetic cardiomyopathy is characterized by cardiac structural and functional abnormalities. Additionally, chronic pressure overload conditions are highly prevalent amongst diabetic population and this association leads to a more severe myocardial impairment. The differences in myocardial pathophysiology between type 1 and type 2 diabetes mellitus (DM) still remain to be clarified. Thus, we aimed to investigate biventricular structural and functional changes promoted by the two types of DM and the impact of concomitant chronic pressure overload.
METHODS: Wistar rats were injected with streptozotocin (Type 1 DM, T1DM) or fed with a hypercaloric diet (Type 2 DM, T2DM). Pressure overload was imposed in DM animals by aortic constriction and after 5weeks of DM the cardiac function and structure were evaluated.
RESULTS: Both types of DM promoted hypertrophy, increased fibrosis and advanced glycation end-products deposition, in the two ventricles. Interestingly, the induced myocardial alterations were distinct. While T1DM stimulated a pronounced hypertrophy and extracellular matrix remodeling, T2DM induced functional impairment. The negative impact of the association of DM with aortic constriction was more pronounced in T2DM, promoting impaired function and increased stiffness, particularly in the right ventricle.
CONCLUSIONS: Our study demonstrated that the two types of diabetes induce distinct cardiac alterations per se or when combined with chronic pressure overload. T1DM promoted a more extensive remodeling in cardiac structure while T2DM significantly impaired ventricular function. The impact of pressure overload was more notorious in T2DM as observed by worse myocardial remodeling, suggesting a higher susceptibility to the deleterious effects of chronic pressure overload, namely hypertension, among this diabetic population.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac function; Chronic pressure overload; Diabetes mellitus; Myocardial remodeling

Mesh:

Substances:

Year:  2016        PMID: 27195451     DOI: 10.1016/j.ijcard.2016.04.178

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

Review 1.  Fibroblasts and the extracellular matrix in right ventricular disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2017-10-01       Impact factor: 10.787

2.  Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.

Authors:  C M Rosa; R Gimenes; D H S Campos; G N Guirado; C Gimenes; A A H Fernandes; A C Cicogna; R M Queiroz; I Falcão-Pires; D Miranda-Silva; P Rodrigues; F R Laurindo; D C Fernandes; C R Correa; M P Okoshi; K Okoshi
Journal:  Cardiovasc Diabetol       Date:  2016-09-01       Impact factor: 9.951

3.  Longitudinal Evaluation of Myocardial Fatty Acid and Glucose Metabolism in Fasted and Nonfasted Spontaneously Hypertensive Rats Using MicroPET/CT.

Authors:  Jennifer S Huber; Andrew M Hernandez; Mustafa Janabi; James P O'Neil; Kathleen M Brennan; Stephanie T Murphy; Youngho Seo; Grant T Gullberg
Journal:  Mol Imaging       Date:  2017 Jan-Dec       Impact factor: 4.488

Review 4.  Heat Shock Protein 22 in Physiological and Pathological Hearts: Small Molecule, Large Potentials.

Authors:  Xiaonan Sun; Sharadhi Siri; Amirah Hurst; Hongyu Qiu
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

Review 5.  Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects.

Authors:  Thiago Melo Costa Pereira; Fabio Silva Pimenta; Marcella Lima Porto; Marcelo Perim Baldo; Bianca Prandi Campagnaro; Agata Lages Gava; Silvana Santos Meyrelles; Elisardo Corral Vasquez
Journal:  Int J Mol Sci       Date:  2016-08-05       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.